Diabetes Mellitus, Type 1
Showing NaN - NaN of 33
Diabetes, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia Trial in Canada, United States (VX-880)
Recruiting
- Diabetes Mellitus, Type 1
- +2 more
- VX-880
-
Duarte, California
- +10 more
Aug 8, 2022
Diabetes, Type 1 Trial in United States (MYL-1601D Product, FlexPen NovoLog®)
Completed
- Diabetes Mellitus, Type 1
- MYL-1601D Product
- FlexPen NovoLog®
-
Montgomery, Alabama
- +157 more
Feb 23, 2022
TrialNet Pathway to Prevention of T1D
Recruiting
- Diabetes Mellitus, Type 1
-
Orange, California
- +21 more
Feb 18, 2022
Diabetes, Type 1 Diabetes, Diabetes, Type 1 Trial in United States (Bionic Pancreas)
Completed
- Diabetes Mellitus
- +2 more
- Bionic Pancreas
-
Orange, California
- +15 more
Jan 17, 2022
Patient and Parent Preferences forOn-Body Automated Insulin
Completed
- Diabetes Mellitus, Type 1
-
New Haven, Connecticut
- +1 more
Aug 3, 2021
Diabetes, Type 1 Trial in Boston (high GI meal, low GI meal, euglycemic insulin clamp)
Completed
- Diabetes Mellitus, Type 1
- high GI meal
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
May 25, 2021
Diabetes, Type 1 Trial in Boston (Insulin Lispro, ZP4207 (dasiglucagon), Glucagon)
Completed
- Diabetes Mellitus, Type 1
- Insulin Lispro
- +4 more
-
Boston, MassachusettsMGH Diabetes Center
Feb 26, 2021
Diabetes, Type 1, Diabetes, Type 1 Diabetes Trial in Boston (No intervention)
Recruiting
- Diabetes Mellitus, Type 1
- +3 more
- No intervention
-
Boston, MassachusettsT1D Exchange
Nov 9, 2020
Diabetes, Type 1 Trial in United States (TOL-3021, TOL-3021 Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 1
- TOL-3021
- TOL-3021 Placebo
-
San Diego, California
- +22 more
Nov 5, 2020
Technology to Improve Glucose Control in Type 1 Diabetes
Completed
- Diabetes Mellitus, Type 1
- Meal-Tagging App
- Fitness Tracker
-
Boston, MassachusettsJoslin Diabetes Center
Aug 20, 2020
Diabetes, Type 1 Trial in Boston (Fast-acting insulin aspart, iLet™)
Completed
- Diabetes Mellitus, Type 1
- Fast-acting insulin aspart
- iLet™
-
Boston, MassachusettsNovo Nordisk Investigational Site
May 28, 2020
Diabetes, Type 1 Trial in Canada, United States (Mycophenolate mofeteil (MMF), Daclizumab (DZB), Placebo control for
Completed
- Diabetes Mellitus, Type 1
- Mycophenolate mofeteil (MMF)
- +3 more
-
Los Angeles, California
- +10 more
Apr 27, 2020
Diabetes, Type 1 Trial in Canada, United States (Parenteral Insulin, Close Observation, Oral Insulin)
Completed
- Diabetes Mellitus, Type 1
- Parenteral Insulin
- +3 more
-
Los Angeles, California
- +14 more
Apr 22, 2020
Diabetes, Type 1 Trial in Boston, Philadelphia (G-Pen Mini™ (glucagon injection), Glucose Tabs, Basal Insulin Reduction)
Completed
- Diabetes Mellitus, Type 1
- G-Pen Mini™ (glucagon injection)
- +2 more
-
Boston, Massachusetts
- +1 more
Feb 28, 2020
Diabetes, Type 1 Trial in United States (G-Pen Mini™ (glucagon injection), Glucose Tablets)
Completed
- Diabetes Mellitus, Type 1
- G-Pen Mini™ (glucagon injection)
- Glucose Tablets
-
Aurora, Colorado
- +4 more
Feb 28, 2020
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- insulin aspart
-
Encino, California
- +91 more
Nov 12, 2019
Insulin Treated Type 2 Diabetes, Diabetes, Type 1 Trial in Boston (Control:Diabetes mobile app)
Unknown status
- Insulin Treated Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Control:Diabetes mobile app
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 7, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Little Rock, Arkansas
- +80 more
Jun 3, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Phoenix, Arizona
- +154 more
May 22, 2019
Diabetes, Type 1 Trial in United States (Aralast NP 45 mg dose, Aralast NP 90 mg dose, Aralast NP 180 mg dose)
Terminated
- Diabetes Mellitus, Type 1
- Aralast NP 45 mg dose
- +2 more
-
San Diego, California
- +14 more
May 14, 2018
Diabetes, Type 1 Trial in Worldwide (Artificial Pancreas)
Completed
- Diabetes Mellitus, Type 1
- Artificial Pancreas
-
Santa Barbara, California
- +9 more
May 1, 2018
Diabetes, Type 1 Trial in Boston (Peer-Based Web-Based Health Information, Provider-Based Web-Based Health Information)
Completed
- Diabetes Mellitus, Type 1
- Peer-Based Web-Based Health Information
- Provider-Based Web-Based Health Information
-
Boston, MassachusettsBoston Children's Hospital
Nov 13, 2017
Type One Diabetes and Low Carb Study
Completed
- Diabetes Mellitus, Type 1
-
Boston, MassachusettsBoston Children's Hospital
Jun 7, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Duarte, California
- +15 more
Feb 28, 2017
Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin lispro
- insulin aspart
-
Mobile, Alabama
- +51 more
Dec 21, 2016